Health concerns associated with travelling with inflammatory bowel disease (IBD): a questionnaire survey.

作者: Varun Philip , Anet Soubieres , Andrew Poullis

DOI: 10.7861/CLINMEDICINE.18-4-288

关键词:

摘要: ABSTRACT When travelling, patients with inflammatory bowel disease (IBD) have a higher risk of morbidity. We identified barriers to travel, specific health concerns and several areas for service improvement among patients. In total, 136 were given 32-question questionnaire. Of these, 89% travelled abroad, 30% reported that IBD limited travel 40% said it affected choice destination. Fourty-seven percent abroad without insurance 7% refused. Seventy-eight wanted pre-travel advice from doctors in the future. Popular options included providing written prescriptions (91%) management plans (75%). Sixty-three unaware needing avoid live vaccines while on immunosuppressants. Ninety-two high altitudes could precipitate flares; 27% high-altitude destinations, which 46% subsequently had flare-ups. Existing services remain unknown such as ‘Can’t wait’ card (72%) ‘IBD passport’ (96%). Service improvements clinic need be implemented facilitate safer overseas.

参考文章(10)
Kay Greveson, Thomas Shepherd, John P Mulligan, Mark Hamilton, Sue Woodward, Christine Norton, Charles Murray, Travel health and pretravel preparation in the patient with inflammatory bowel disease Frontline Gastroenterology. ,vol. 7, pp. 60- 65 ,(2016) , 10.1136/FLGASTRO-2014-100548
Stephan R. Vavricka, Gerhard Rogler, Sandra Maetzler, Benjamin Misselwitz, Ekaterina Safroneeva, Pascal Frei, Christine N. Manser, Luc Biedermann, Michael Fried, Peter Higgins, Kacper A. Wojtal, Alain M. Schoepfer, High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients Journal of Crohn's and Colitis. ,vol. 8, pp. 191- 199 ,(2014) , 10.1016/J.CROHNS.2013.07.011
Shomron Ben–Horin, Yoram Bujanover, Shulamit Goldstein, Moshe Nadler, Alon Lang, Uri Kopylov, Lior Katz, Adi Lahat, Eli Schwartz, Benjamin Avidan, Travel-Associated Health Risks for Patients With Inflammatory Bowel Disease Clinical Gastroenterology and Hepatology. ,vol. 10, pp. 160- 165 ,(2012) , 10.1016/J.CGH.2011.10.025
J.F. Rahier, F. Magro, C. Abreu, A. Armuzzi, S. Ben-Horin, Y. Chowers, M. Cottone, L. de Ridder, Doherty G., R. Ehehalt, M. Esteve, K. Katsanos, C.W. Lees, E. MacMahon, T. Moreels, W. Reinisch, H. Tilg, L. Tremblay, G. Veereman-Wauters, N. Viget, Y. Yazdanpanah, R. Eliakim, J.F. Colombel, Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease Journal of Crohn's and Colitis. ,vol. 8, pp. 443- 468 ,(2014) , 10.1016/J.CROHNS.2013.12.013
MGVM Russel, BM Ryan, PC Dagnelie, M de Rooij, J Sijbrandij, A Feleus, M Hesselink, JW Muris, R Stockbrugger, Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study Gut. ,vol. 52, pp. 358- 362 ,(2003) , 10.1136/GUT.52.3.358
J.-F. Rahier, M. Moutschen, A. Van Gompel, M. Van Ranst, E. Louis, S. Segaert, P. Masson, F. De Keyser, Vaccinations in patients with immune-mediated inflammatory diseases Rheumatology. ,vol. 49, pp. 1815- 1827 ,(2010) , 10.1093/RHEUMATOLOGY/KEQ183
Gil Y. Melmed, Seper Dezfoli, Vaccination Issues in Patients with Inflammatory Bowel Disease Receiving Immunosuppression Gastroenterología y Hepatología. ,vol. 8, pp. 504- 512 ,(2012)
Francis A Farraye, Sharmeel Wasan, Jason Reich, Vaccinating Patients With Inflammatory Bowel Disease. Gastroenterología y Hepatología. ,vol. 12, pp. 540- 546 ,(2016)